Washington [US], October 22 (ANI): A new study may prompt medical experts to rethink when to start mammograms for women who have a mother, sister or daughter diagnosed with breast cancer.
Philadelphia [US], October 18 (ANI): Bipolar disorder, a neuropsychiatric illness characterised by manic and depressed episodes, affects around 1 per cent of the population and is heavily impacted by heredity.
North Carolina [US], October 9 (ANI): Researchers at the UNC School of Medicine have made important strides in the exciting fields of cellular reprogramming and organ regeneration, and their findings could have a substantial impact on the development of future treatments for broken hearts.
North Carolina [US], October 7 (ANI): Researchers at the UNC School of Medicine have made important strides in the exciting fields of cellular reprogramming and organ regeneration, and their findings could have a substantial impact on the development of future treatments for broken hearts.
Researchers in the United States have developed an inhalable, self-administered COVID-19 vaccine that is shelf-stable at room temperature for up to a duration of three months. The researchers discovered that this delivery mechanism, an exosome produced from the lung and termed LSC-Exo, is more effective for avoiding the lung’s lining than the lipid-based nanoparticles currently […]
Chapel Hill [North Hill], April 10 (ANI): A new study has looked at multiple levels of biology within women with postpartum depression (PPD) to see how women with the condition differ from those without it.
Washington [US], March 10 (ANI): A new study has outlined 150 years of sea-surface temperature history throughout the Greater Caribbean region, highlighting significant warming trends that have disrupted coral reef ecosystems.
Chapel Hill [US], January 19 (ANI): A new research has found that COVID-19 vaccination offers long-lasting protection from the worst outcomes of COVID-19.
Washington [US], November 2 (ANI): Research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.